Part, Chapter, Paragraph
1 -, 1 | Agencies (Appendix 3); and (v) considered by the Drafting
2 -, 1 | analysis; (iv) Risk factors; (v) Control tools and policies; (
3 II, 5. 2. 6| Lekos D, Monti M, Puddu V, Taylor HL (1966). Epidemiological
4 II, 5. 2. 7| Allender S, Scarborough P, Peto V and Rayner M (2008): European
5 II, 5. 2. 7| 2008).~Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez
6 II, 5. 2. 7| E, Tuomilehto J, Salomaa V, Nissinn A (1998): Changes
7 II, 5. 3. 2| of “Cancer Incidence in V Continents” and to produce
8 II, 5. 4. 8| Mazovetsky A, Olchanski V., (1995) A computerized
9 II, 5. 5. 1| Gasquet I, Torres JV, Kovess V, Kessler RC, Alonso J and
10 II, 5. 5. 1| 17–30.~ ~Kovess-Masféty V, Alonso J, Brugha TS, Angermeyer
11 II, 5. 5. 3| Samdal O, Barnekow Rasmussen V, eds. Available at: htt f (
12 II, 5. 5. 3| Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC,
13 II, 5. 5. 3| s15-s20.~Prince M, Patel V, Saxena S, Maj M, Maselko
14 II, 5. 5. 3| 412.~Endziniene M, Pauza V, Miseviciene V (1997): Prevalence
15 II, 5. 5. 3| M, Pauza V, Miseviciene V (1997): Prevalence of childhood
16 II, 5. 5. 3| Vukusic S, Van Bockstael V, Gosselin S, Confavreux
17 II, 5. 5. 3| allocates stages from I to V to indicate the relative
18 II, 5. 5. 3| costs in HY stages IV and V has been reported, demonstrating
19 II, 5. 5. 3| international studies (Schöffski and v.d. Schulenburg, 2007).~ ~
20 II, 5. 5. 3| Kingdom WK, MacMahon DG, Peto V, Playfer JR (2003): Direct
21 II, 5. 5. 3| Carreras M, Casetta I, Govoni V, Tola MR, Paolino E, Monetti
22 II, 5. 5. 3| 502.~Nicoletti A, Sofia V, Bartoloni A, Bartalesi
23 II, 5. 5. 3| 3):250-255~Schöffski O, v.d. Schulenburg J-M., 2007.
24 II, 5. 6. 6| Nguyen M, Thiesce A, Listrat V, Jacob L, Nakache JP, Gabriel
25 II, 5. 6. 6| 111:87-98~Lock C, Allgar V, Jones K, Marples G, Chandler
26 II, 5. 7. 1| dialysis)~585.5~585.6 (if ESRD)~V codes for dialysis or transplantation~
27 II, 5. 7. 7| 2005.~Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani
28 II, 5. 8. 7| BM, Petersen LJ, Backer V (2007): The prevalence of
29 II, 5. 8. 7| 773.~ ~Masa JF, Sobradillo V, Villasante C, Jimenez-Ruiz
30 II, 5. 9. 4| Cladosporium herbarium; (v) Alternaria alternata; (
31 II, 5. 9. 4| of PM such as vanadium (V), nickel (Ni), zinc (Zn),
32 II, 5. 9. 4| correlations were observed between V, Ni, and SO(4) and the allergen
33 II, 5. 10. 7| Res 51, 135-147.~ ~Brusic V, Millot M, Petrovsky N,
34 II, 5. 11. 7| 126.~ ~Diepgen TL, Mahler V (2002): The epidemiology
35 II, 7. 5 | evidence-based approaches; and (v) to participate in international
36 II, 8. 2. 1| J. and Rutkowski-Kmitta, V. (2005). Disability Statistics
37 II, 8. 2. 1| Borthwick-Duffy, S., Bradley,V., Buntinx, W.H.E., Coulter,
38 II, 8. 2. 3| Assennato G, Sallustio V (1996): Epidemiology of
39 II, 9. 1. 1| 2002;103(1):4-13.~Apgar V (1953): A t. Curr. Res.
40 II, 9. 1. 2| Goujard J, Steinbicker V, Roesch C, McDonnell R,
41 II, 9. 1. 2| Gatt M, McDonnell R, Nelen V and Stone D (2005c): "Survey
42 II, 9. 1. 2| Garne E, Loane M, Nelen V, Bakker M, Gener B, Abramsky
43 II, 9. 3. 1| 84(1): p. 50-56.~ ~Beral V (2003): Breast cancer and
44 II, 9. 3. 1| Wilhelm K, Barclay L & Schmied V (2005): 'Big build': hidden
45 II, 9. 3. 1| 723-754.~ ~Qaseem, A Snow, V Shekelle, P Hopkins Jr R.
46 II, 9. 3. 2| Marpeau L, Marchand L, Pierrat V, Larroque B, et al (2007):
47 II, 9. 3. 3| Samdal O, Barnekow Rasmussen V (2004) Young people’s health
48 II, 9. 5. 6| RoutledgeFalmer.~ ~Beral V 2003: Breast cancer and
49 II, 9. 5. 6| Denton M, Prus S, Walter V (2004): Gender differences
50 III, 10. 1. 3| Rev 19(5):513-530.~Burke V, Beilin LJ, Milligan R,
51 III, 10. 1. 3| Solorzano R, Kelley M, Darrow V, Gendrop SC, Strickland
52 III, 10. 1. 3| N, Armstrong T, Candeias V, Keller I, Riley L, Roy
53 III, 10. 2. 1| mortality among drug users; (v) demand for drug treatment),
54 III, 10. 2. 1| Samdal O, Barnekow Rasmussen V, eds (2004): Young people’
55 III, 10. 2. 1| Gallus S, Colombo P, Scarpino V, Zuccaro P, Negri E, Apolone
56 III, 10. 2. 1| 1174-1179.~ ~Grabauskas V, Klumbienė J, Petkevičienė
57 III, 10. 2. 1| Šakytė E, Kriaučionienė V, Paalanen L, Prättälä R (
58 III, 10. 2. 1| Kapantais E, Haralambides V, Tzotzas T, Mortoglou A,
59 III, 10. 2. 1| Yeh MC, Nawaz H, Njike V, Anderson LM, Cory S, Dietz
60 III, 10. 2. 1| Telesný vývoj detí a mládeže v Slovenskej republike [Physical
61 III, 10. 2. 1| Paccaud F, Wietlisbach V, Rickenbach M (2001): Body
62 III, 10. 2. 1| Mourão I, Moreira P, Rosado V (2004): Prevalence of overweight
63 III, 10. 2. 1| Grīnberga D, Villeruša A, Dzērve V, Zīle S, Helasoja V, Paalanen
64 III, 10. 2. 1| Dzērve V, Zīle S, Helasoja V, Paalanen L, Prättälä R (
65 III, 10. 2. 1| M, Lagiou P, Kalapothaki V, Evangelista A, Frasca G,
66 III, 10. 2. 1| K, Lagiou P, Kalapothaki V, Masala G, Giurdanella MC,
67 III, 10. 2. 1| Vasilopoulou E, Bellos G, Pala V, Masala G, Tumino R, Sacerdote
68 III, 10. 2. 1| San-Jose B, Welch AA, Krogh V, Luben R, Allen N, Overvad
69 III, 10. 2. 1| Klipstein-Grobusch K, Benetou V, Zavitsanos X, Tumino R,
70 III, 10. 2. 5| J, Ispanovic-Radojkovic V, Paradisiotou A, Tamminen
71 III, 10. 2. 5| J, Ispanovic-Radojkovic V, Rudic N, Tamminen T, Turunen
72 III, 10. 4. 2| wound infection~ ~High (V. vulnificus),~ ~ ~ ~Medium (
73 III, 10. 4. 2| pesticides. Particularly, Chapter V (articles 26 through 34)
74 III, 10. 5. 1| 15(1-2): 1-12.~Loftness V, Hakkinen B, Adan O, Nevalainen
75 III, 10. 6. 1| Richter M, Morgan A, Barnekow V (Eds.). HBSC international
76 IV, 11. 6. 5| 1162.~ ~Goldfarb NI, Maio V et al. (2003): How Does
77 IV, 12. 10 | Campaign: FA C T S A N D A D V I C E~about smoking and
78 IV, 12. 10 | according to § 20 Abs. 1 SGB V (Social Code Book V, Prevention
79 IV, 12. 10 | SGB V (Social Code Book V, Prevention and health promotion),
80 IV, 12. 10 | related.~§ 20 Abs. 1 SGB V (Social Code Book V, Prevention
81 IV, 12. 10 | SGB V (Social Code Book V, Prevention and health promotion):
82 IV, 12. 10 | interventions.~§ 21 SGB V (prevention of dental diseases):
83 IV, 12. 10 | well (legal basis: § 43 SGB V and SGB IX).~National health
84 IV, 12. 10 | programs according to § 20 SGB V (see above) and of different
85 IV, 12. 10 | health promotion. According to § 65 SGB V Statutory Sickness Funds
86 IV, 12. 10 | Intermediate~ ~§ 21 SGB V prevention of dental diseases:
87 IV, 12. 10 | out by dentists,~§ 22 SGB V prevention of dental diseases:
88 IV, 12. 10 | activities~ ~§ 20 Abs. 1 SGB V (Social Security Code V)
89 IV, 12. 10 | V (Social Security Code V) Prevention and Health Promotion
90 IV, 12. 10 | employer’s duty(1996)~§20b SGB V; Act on prevention of work-related
91 IV, 12. 10 | Hypertension~High priority~§ 25 SGB V Preventive Health examination (
